From the Global Health Innovators Index, Thoratec (THOR) posted strong data on Friday for its HeartMate II pump among heart failure patients who are not eligible for a transplant. The positive data came much earlier than expected and allows Thoratec to apply for approval of the device during 1H09. THOR traded near all-time highs on Friday on over 3X average trading volume on favorable prospects for approval of the device during the first half of 2010.
VCR
ventracor limited
From the Global Health Innovators Index, Thoratec (THOR) posted...
Add to My Watchlist
What is My Watchlist?